PEOPLE
Members of the Drew Lab and CTEU Biobank Staff
Past Mentees / Position (Next Stop):
Vincent M. Battista, PH.D. / Sr. Data Analyst (Bristol Myers Squibb)
Connor Geraghty, PH.D. / T32 Post-doctoral Fellow (Sr. Computational Biologist, Merck)
Takuma Higurashi, M.D. PH.D. / Research Fellow (Yokohama City University School of Medicine)
Laboratory Alumni / Position (Next Stop):
Samantha Chin / CRC (MSTP at Washington University School of Medicine in St. Louis)
Zahra Fatehi / CRC I (Lake Erie College of Osteopathic Medicine)
Jackie Flynn / CRC (Tufts School of Dental Medicine)
Kate Gilpin / CRC II (Aetion - Healthcare Tech)
Alina Husain / Research Intern - CRC (Weill Medical College of Cornell University)
Madeline (Madie) Koehn / CRC II (Sidney Kimmel Medical College at Thomas Jefferson University)
Jesus Luevano, M.D. / IM Resident (Columbia University Vagelos College of Physicians and Surgeons - GI Fellowship)
Claude Luvier-Bonnet / CRC (Yale School of Nursing)
Jennifer Mackinnon Krems / CRC (UCSF School of Medicine)
Deepika Mehra, PH.D. / Research Tech II (Post-Doctoral Fellow - Russell lab - MGH)
Dana Meixell / CRC (Netter School of Medicine at Quinnipiac University)
Patrick Miller / Research Tech II (Alnylam Pharmaceuticals, Inc.)
Melanie Parziale / CRC (Larner College of Medicine at the University of Vermont)
Emily Pond / Research Tech II (Johns Hopkins Bloomberg School of Public Health)
Elizabeth Prezioso / CRC II (Sidney Kimmel Medical College Thomas Jefferson University)
Trenton (Trent) Reinicke / CRC II (Oakland University William Beaumont School of Medicine)
Rebecca Rojas / Research Technologist (JEDI Fellow MGH Institute of Health Professionals)
Madeline Schuck, P.A. / Clinical Research Project Manager (MGH-IHP / MGH Gyn Onc)
Janavi Sethurathnam / CRC II (Vanderbilt University School of Medicine)
Julia Solowey / CRC II (Larner College of Medicine at the University of Vermont)
Oliver Takacsi-Nagy / CRC II (ArsenalBio)
Jacqueline Woo / CRC II (Columbia University Post-Bac Program)
Dylan Zerjav / CRC II (Geisel School of Medicine at Dartmouth)
DAVID A. DREW, PH.D.
Principal Investigator / Director of Biobanking
Dr. Drew is an Assistant Professor of Medicine with the Clinical & Translational Epidemiology Unit (CTEU) and Division of Gastroenterology at Massachusetts General Hospital and Harvard Medical School. His specific research interests are in the identification, interception and precision prevention of gastrointestinal cancers and other diseases. He has a specialized expertise in clinical trial design and implementation, especially with respect to studies of the gut microbiome and precision risk biomarkers. His research is highly collaborative and achievements have been nationally and internationally recognized by professional organizations, including the American Association for Cancer Research, the American Gastroenterological Association, and Aspirin for Cancer Prevention/European Hereditary Tumor Group. He is funded by the NIH/NIDDK (K01DK120742), the American Gastroenterological Association, and is an NIH Loan Repayment Ambassador through the NCI (L30CA209764). He is an early career investigator on the Stand Up To Cancer Gastric Cancer Early Detection and Interception Team, the Stand Up to Cancer Colorectal Cancer Health Equity Dream Team, and within the Clinical Center for NIH's Nutrition for Precision Health: The All of Us New England Research Collaborative.
He has received past funding from the MGH Center for the Study of Inflammatory Bowel Disease (CSIBD) and a Cancer Epidemiology Training grant (T32CA009001). Dr. Drew received a B.S. in Biochemistry/Biophysics from Rensselaer Polytechnic Institute (2009) and a PH.D. in Biomedical Science from UConn Health (2014; Mentor, Daniel W. Rosenberg, PH.D.)
In addition to his research activities, as Director of Biobanking for the CTEU, Dr. Drew manages the clinical trials portfolio and biobanking efforts of the CTEU. He oversees a team consisting of a project manager, clinical research coordinators and laboratory technicians to shepherd other investigators through protocol development, IRB approval, clinical implementation, laboratory/biobanking procedures, and regulatory compliance.